Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
04 October 2023 | Story Prof Robert Bragg | Photo Supplied
Prof Robert Bragg
Prof Robert Bragg is from the Veterinary Biotechnology in the Department of Microbiology and Biochemistry, University of the Free State (UFS).

Opinion article by Prof Robert Bragg, Veterinary Biotechnology in the Department of Microbiology and Biochemistry, University of the Free State.


The poultry sector in South Africa is currently undergoing serious challenges. 

The ongoing load shedding and power disruptions have put tremendous pressure and additional costs on the industry, which makes producing poultry products extremely expensive. One company (Astral Foods) has spent an additional R919 million as a result of load shedding alone. This has obviously had a significant impact on the profitability and sustainability of the company.

Now to make matters worse – the local poultry industry has been hit with a major avian influenza epidemic.

Avian Influenza (AI) is a viral disease of birds, including poultry. The term “AI” is frequently in the news these days and often refers to artificial intelligence. In this article, the term AI refers to Avian Influenza. This is a devastating disease of poultry and can wipe out a flock in just a few days. AI is the most widely-studied disease of poultry as it has been causing major problems in poultry industries around the world for many years.

Reluctance to vaccinate 

In the past (five to 10 years ago) Avian influenza (AI), was pretty much the only serious poultry disease which South Africa did not have. There have been cases of what is called low pathogenic Avian Influenza in ostriches for some time. However, the commercial poultry industry was, for a long time, free of the highly pathogenic strain of the virus. This is now, unfortunately, no longer the case.

In the past, Veterinary Services was reluctant to allow vaccination of poultry in South Africa against AI. Most of the major international vaccine manufacturers have highly effective vaccines against AI, which are widely used in many countries where AI has become well-established. There were two reasons for this reluctance to allow vaccination against AI. Firstly, there is a well-organised and -run surveillance system in place for AI in South Africa. The basis of this monitoring programme is routinely looking for antibodies against AI in commercial poultry. This surveillance system is only possible if the birds are not vaccinated. The control policy in the past was a “stamping-out” policy. In other words, when AI is detected in a flock, the flock is destroyed. Secondly, AI has not been a major problem in South Africa in the past and the previous outbreaks were successfully controlled with the stamping-out policy which was in place. Previous AI outbreaks were successfully controlled. 

All this has now changed and AI is running rampant. The consequences of this will be severe.

The commercial poultry industry is based on two different types of birds – the layers and the broilers. The layers, as the name suggests, are the birds which lay eggs for human consumption. The broiler birds are the meat birds. In order to maintain the supply of both meat and eggs, there is a complex system of breeder birds, grandparents and great grandparents. These breeder birds are genetic line birds and play a critical role in keeping the market supplied with poultry products. If (and when) these breeder birds contract AI, they will die (either from the virus infection or from the control efforts). When this happens, the constant supply of hatching eggs needed to keep the layer and broiler farmers supplied with chickens to meet the constant demand for poultry products will be gone. In other words, there will be a major shortage of poultry. As poultry is the most affordable source of protein, this will cause major food shortages and additional hunger problems.

Antibodies vs viruses 

There are efforts to now import vaccines against AI. This will assist with the control of the disease in the long term, but will, unfortunately, not do much to control the current problem in the short term. The reason for this is that it takes time for vaccinated birds to develop antibodies against the virus. As soon as the birds are vaccinated, their immune system will start to make antibodies. Only when there are enough antibodies, will the birds be protected. It can take up to two weeks to get sufficient antibodies. Even then, if there is too much virus in the field, the immune response of the birds can still be overwhelmed. In simple terms, if the bird has a number of antibodies (let’s use an understandable number to explain) of 10 antibodies and there are nine viruses, the antibodies win and the birds are safe. If there are 10 antibodies, but 11 viruses – the viruses win and the birds die. Obviously, these numbers are not the real numbers and are just used as an explanation. In the major Newcastle disease (NCD) outbreak in the late 1990s, the birds had very high levels of antibodies against NCD and should have been protected. However, there was so much circulating virus that the immune system of the birds were overwhelmed and this outbreak was very difficult to control.

The only short-term option for control of AI in the current situation is good biosecurity. It is essential that good biosecurity is in place on the poultry farms. Only high-quality, registered disinfectants must be used for the biosecurity efforts. The ideal product would be one which is non-toxic to the birds and can be used to continually reduce the levels of viruses in the flocks. Until the vaccination programme can take effect, the only control option is a full continual disinfection programme which would include using the disinfectant in the drinking water, provided that the product is registered for this application and also to regularly spray the birds – again only if the product is registered for this application. The registration of a product ensures that the label claims can be substantiated and there is valid scientific evidence to support the claims made by the producers of the product. 

The long-term consequences of this AI infection coupled with the constant problems with load shedding will be the death blow to many small- and medium-sized poultry farmers. It may even become very difficult for the large poultry companies to survive the current crisis. In order to meet the demand for poultry products, South Africa will most likely become even more reliant on imported poultry products, which is another bone of contention.

News Archive

Great turnout for Hannes Meyer Symposium in Cardiothoracic Surgery
2017-05-05

Description: Hannes Meyer Symposium  Tags: Hannes Meyer Symposium

Symposium attendees watch attentively as
Dr Johan Brink demonstrated a MAZE procedure
with a pig’s heart.
Photo: Supplied

The University of the Free State’s Faculty of Health Sciences hosted the annual Hannes Meyer Symposium in Cardiothoracic Surgery. The symposium was organised by Prof Francis Smit, head of the department of Cardiothoracic Surgery at the UFS, with the support from the Society of Cardiothoracic Surgeons of South Africa and the European Association of Cardiothoracic Surgery (EACTS). Over the past 16 years this symposium has steadily been growing in stature and prestige leading to the resounding success that was this year’s event.

Medical advancements explored
The aim of the symposium is to provide an overview of the latest advances in Cardiothoracic Surgery and perfusion as well as providing hands-on training via simulation to trainees from South Africa and the rest of the African continent. Didactic lectures and papers by registrars were an integral component of the symposium. The South African community was represented by various heads of departments, trainees, senior specialists and perfusionists from all the training centres in the country. There were also delegates representing Uganda, Mozambique, Nigeria and Zambia.

Heart surgery off to new heights
Simulation in Cardiothoracic Surgery and Perfusion can be compared to airline pilots with high risk, with complex surgeries being first done in simulators before being attempted in the real world. The UFS is proud to have a state-of-the-art simulation facility, which was used to facilitate the programme.

The range of simulation was extensive and included simple procedural models to complex full theatre setups with Human Performance Models in perfusion that simulated crisis scenarios with the aid of computerised devices that react in real time to human intervention.

Industry support highly appreciated
This event was coordinated by Dr Jehron Pillay, senior registrar in the Department of Cardiothoracic Surgery and Marilee Janse van Vuuren, deputy-director clinical technology, in the department. This was the first time that such extensive simulation models were used in the programme and judging from the positive response received, it has certainly set the benchmark for all future events.

The event has received invaluable support over the years from EACTS that has selected Bloemfontein as the site of its African training programme as a result of the high level of training and education achieved here.

The academic discussions were chaired by Profs Marko Turina and Jose Pomar (past presidents of EACTS) and Pieter Kappetein (past secretary general of EACTS) who are extremely well known internationally for their contribution to advancing Cardiothoracic training and education.

Our guests from EACTS presented didactical lectures on research methodology, international randomised trials and discussed recent developments and controversies in cardiothoracic surgery.

Registrars from all South African units presented a thoracic and cardiac surgery paper from each unit highlighting specific disease conditions, moderated by heads of departments and the international panel.

An event of this magnitude requires significant financial support and the medical industry in South Africa stepped up to the plate in providing financial and logistical support in order to make it possible.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept